Loading clinical trials...
Loading clinical trials...
This is a multicentre, multinational clinical study. It comprised two consecutive segments (A and B). Segment A was designed as a randomized, double-blind, double-dummy, active-controlled, two-arm par...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Dr. Falk Pharma GmbH
NCT06455280 · Autoimmune Liver Disease, Liver Transplant Disorder, and more
NCT04902807 · Autoimmune Lymphoproliferative Syndrome, Autoimmune Cytopenia, and more
NCT03146884 · Hepatitis, Autoimmune, Autoimmune Hepatitis
NCT05750498 · Autoimmune Hepatitis, Primary Sclerosing Cholangitis
NCT05810480 · Autoimmune Hepatitis, Autoimmune Liver Disease
Medical School Hannover
Hanover, Lower Saxony
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions